Jun 8, 2020 | News, Regulatory
The World Health Organization (WHO) has prequalified a biosimilar of version of rituximab, which is used to treat certain cancers and autoimmune diseases, created by Celltrion. This drug therapy is the second to achieve prequalification status under the... 
May 11, 2020 | News, Regulatory
The FDA announced on Friday (5/8) of its approval for Retevmo, a drug capsule created by Eli Lilly for patients diagnosed with a specific RET gene mutation for three kinds of tumors: non-small cell lung cancer, medullary thyroid cancer and other types of thyroid... 
Jan 20, 2020 | News, Regulatory
The Theory At the American Society of Clinical Oncology (ASCO), FDA Commissioner Dr. Scott Gottlieb introduced the Drug Competition Action Plan, which aims to lower new drug pricing by increasing generic (alternative) drug competition in the pharmaceutical market.... 
Jan 22, 2019 | Clinical Trials, Pharmaceuticals
According to the CDC, 650,000 patients receive chemotherapy every year in the U.S. alone. The side effects are bad enough to cause people to opt into not getting treatment at all. Until now. A new cancer treatment device has been made which reduces the negative...
